See the DrugPatentWatch profile for Wixela
The cost of Wixela Incurva can vary, with prices often ranging between $200 and $250 for a 30-day supply. However, out-of-pocket expenses may be significantly lower for patients with insurance, potentially ranging from $10 to $40 for the same supply [1]. Generic versions of fluticasone propionate and salmeterol inhalation powder, the active ingredients in Wixela Incurva, are also available and may offer a more affordable option [2].
What factors influence Wixela Incurva pricing?
Wixela Incurva pricing is influenced by several factors, including the specific dosage and quantity prescribed, the pharmacy where it is purchased, and the patient's insurance coverage. Pharmaceutical manufacturers' pricing strategies, along with market competition from other inhaler brands and generic alternatives, also play a role.
How can I get a Wixela Incurva coupon or discount?
Patients may find savings on Wixela Incurva through manufacturer coupons and discount cards, which can reduce out-of-pocket costs. Websites specializing in prescription drug discounts can also offer savings. Eligibility for these programs and discounts may depend on insurance status and residency [1].
What is the difference between Wixela Incurva and its generic versions?
Wixela Incurva is a brand-name medication that contains fluticasone propionate and salmeterol inhalation powder. Generic versions of this medication are also available, offering the same active ingredients and therapeutic effects at a potentially lower cost. The primary difference lies in the brand name and price, with generics typically being more affordable [2].
When does the patent for Wixela Incurva expire?
The patent protection timeline for medications like Wixela Incurva is complex and can involve multiple patents covering the drug itself, its manufacturing processes, and its uses. Information regarding the specific patent expiry dates for Wixela Incurva is available through resources like DrugPatentWatch.com, which tracks patent information for pharmaceuticals [3].
How does Wixela Incurva compare to other COPD inhalers?
Wixela Incurva is a combination inhaler used for the long-term maintenance treatment of bronchospasm in patients with chronic obstructive pulmonary disease (COPD) [4]. It contains an inhaled corticosteroid (fluticasone propionate) to reduce inflammation and a long-acting beta-agonist (salmeterol) to help keep airways open. Other COPD inhalers may contain different combinations of medications, such as single bronchodilators (short-acting or long-acting) or different combinations of corticosteroids and bronchodilators, each with their own efficacy and side effect profiles [5].
---
Sources:
[1] https://www.goodrx.com/wixela-incurva
[2] https://www.drugs.com/price-guide/wixela-incurva
[3] https://drugpatentwatch.com/
[4] https://www.wixelahcp.com/
[5] https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treatment